Hainan Poly Pharm. Co., Ltd (SHE:300630)

Hainan Poly Pharm. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	331.37	401.59	777.25	442.26	356.66	198.98
Trading Asset Securities	-	-	0.46	70.55	0.55	-
Cash & Short-Term Investments	331.37	401.59	777.7	512.81	357.21	198.98
Cash Growth	-25.96%	-48.36%	51.65%	43.56%	79.52%	19.52%
Accounts Receivable	1,116	1,263	1,148	947.39	685.98	351.79
Other Receivables	10.27	6.07	14.12	13.88	3.18	2.25
Receivables	1,126	1,269	1,162	961.27	689.16	354.04
Inventory	537.31	359.05	330.34	262.17	94.09	69.72
Prepaid Expenses	-	1.06	1.74	-	-	-
Other Current Assets	177.46	246.37	314.4	288.77	92.33	55.26
Total Current Assets	2,173	2,277	2,586	2,025	1,233	677.99
Property, Plant & Equipment	3,113	3,104	2,900	2,209	1,559	897.35
Long-Term Investments	-	-	-	102.32	-	-
Other Intangible Assets	506.36	370.61	203.83	129.92	94.25	83.67
Long-Term Deferred Tax Assets	96.49	65.72	48.1	32.46	22.31	9.02
Long-Term Deferred Charges	351.47	453.25	359.12	139.76	121.22	28.52
Other Long-Term Assets	14.71	15.9	18.16	24.12	26.21	23.76
Total Assets	6,254	6,287	6,116	4,662	3,056	1,720
Accounts Payable	248.85	343.64	401.99	432.97	279.98	82.02
Accrued Expenses	11.29	68.33	71.81	108.19	80.8	48.66
Short-Term Debt	302.82	384.61	613.39	347.11	169.77	250.59
Current Portion of Long-Term Debt	540.82	513.43	187.08	2.56	4.12	3.13
Current Portion of Leases	-	0.79	0.33	0.57	-	-
Current Income Taxes Payable	2.8	0.55	0.55	36.93	32.03	18
Current Unearned Revenue	240.56	247.81	244.44	40.64	25.52	19.86
Other Current Liabilities	41.19	88.77	357.94	70.7	82.34	10.6
Total Current Liabilities	1,388	1,648	1,878	1,040	674.56	432.85
Long-Term Debt	1,873	1,524	1,481	925.85	206.81	64.65
Long-Term Leases	1.02	2.92	4.69	6.29	-	-
Long-Term Unearned Revenue	139.81	153.5	116.98	83.44	88.24	55.55
Long-Term Deferred Tax Liabilities	43.15	51.75	71.02	65.22	47.25	21.32
Total Liabilities	3,445	3,380	3,551	2,120	1,017	574.37
Common Stock	451.78	451.78	436.35	436.98	436.99	274.76
Additional Paid-In Capital	996.51	996.5	656.55	676.75	664.81	234.75
Retained Earnings	1,371	1,469	1,417	1,318	983.43	636.43
Treasury Stock	-80.35	-80.35	-66.71	-31.42	-46.08	-
Comprehensive Income & Other	69.97	69.03	120.84	141.12	-	-
Shareholders' Equity	2,809	2,906	2,565	2,542	2,039	1,146
Total Liabilities & Equity	6,254	6,287	6,116	4,662	3,056	1,720
Total Debt	2,718	2,426	2,287	1,282	380.7	318.36
Net Cash (Debt)	-2,386	-2,025	-1,509	-769.56	-23.49	-119.39
Net Cash Per Share	-5.50	-4.40	-3.22	-1.75	-0.05	-0.28
Filing Date Shares Outstanding	448.54	448.54	421.23	436.98	437.03	420.99
Total Common Shares Outstanding	448.54	448.54	421.23	436.98	436.99	420.99
Working Capital	784.27	629.33	708.93	985.35	558.23	245.14
Book Value Per Share	6.26	6.48	6.09	5.82	4.67	2.72
Tangible Book Value	2,303	2,536	2,361	2,412	1,945	1,062
Tangible Book Value Per Share	5.13	5.65	5.60	5.52	4.45	2.52
Buildings	-	811.94	709.72	362.33	239.43	149.89
Machinery	-	967.36	800.8	603.46	481.42	363.46
Construction In Progress	-	1,770	1,718	1,482	1,023	520.47

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.